Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus
mBio · 2026
DOI: 10.1128/mbio.01723-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Endrews Delbaje und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biologia, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, São Paulo, Brazil. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Drug Resistance, Fungal, Antifungal Agents, Azoles. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Human fungal infections, especially those caused by Aspergillus fumigatus , pose a significant global health threat, particularly in immunocompromised individuals. Azole antifungals are the primary treatment for this pathogen; however, the prevalence of azole-resistant A. fumigatus strains is steadily increasing. Mutations in cyp51A , which encodes an enzyme involved in ergosterol biosynthesis and the molecular target of the azoles, are well established to confer resistance in this fungal species. However, additional mechanisms governing resistance to this antifungal class remain understudied and poorly characterized, despite growing recognition of their importance in clinical resistance. In this study, we investigated the genetic basis of azole resistance in A. fumigatus isolates from clinical settings worldwide, with a particular focus on mechanisms independent of cyp51A (non-canonical). Using a combination of genomic and functional approaches, including whole-genome sequencing and transcriptomic analysis, we identified novel genetic variants and characterized population structure, advancing our understanding of the genetic diversity and evolutionary dynamics of resistance in A. fumigatus . By expanding our understanding of the complex genetic and molecular factors underlying azole resistance in this important human fungal pathogen, this research is poised to inform the development of novel antifungal strategies and contribute to global efforts to combat fungal infections. IMPORTANCE Azole antifungals are the frontline therapy for infections caused by the opportunistic mold Aspergillus fumigatus , yet resistance to these drugs is rapidly increasing worldwide. Most studies have focused on mutations in cyp51A , the canonical target of azoles; however, a growing proportion of resistant clinical isolates lack these mutations, indicating that alternative resistance mechanisms are emerging. Here, we integrate population genomics, transcriptomics, and functional analyses across a global collection of isolates to define the architecture of cyp51 -independent (non-canonical) azole resistance. We show that this resistance phenotype is strongly associated with a distinct population lineage and is driven by a highly polygenic network of metabolic, mitochondrial, and regulatory adaptations rather than single target site mutations. These isolates exhibit extensive transcriptional rewiring and metabolic remodeling under azole stress, suggesting distinct survival strategies beyond canonical resistance. Our findings reveal that azole resistance in A. fumigatus can evolve through diverse evolutionary routes and emphasize the need to monitor and therapeutically target non-canonical pathways that may increasingly contribute to antifungal treatment failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Biologia, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, São Paulo, Brazil.
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, São Paulo, Brazil.
- Department of Laboratory Medicine, National Reference Centre for Mycosis, University Hospitals Leuven, Leuven, Belgium.
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, KU Leuven, Leuven, Belgium.
- Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
- Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic.
ORCID-Profile: Endrews Delbaje, Katrien Lagrou, Leah E Cowen, Gustavo H Goldman
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Delbaje, E., Ribeiro, M. M., Bitencourt, R. O. B., Lagrou, K., Hubka, V., Pontes, L., Schreiber, A. Z., Robbins, N., Cowen, L. E., Dos Reis, T. F., & Goldman, G. H. (2026). Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus. mBio. https://doi.org/10.1128/mbio.01723-26
Vancouver
Delbaje E, Ribeiro MM, Bitencourt ROB, Lagrou K, Hubka V, Pontes L, et al. Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus. mBio. 2026. doi:10.1128/mbio.01723-26
BibTeX
@article{Delbaje2026,
author = {Delbaje, Endrews and Ribeiro, Matheus Mertz and Bitencourt, Ricardo de Oliveira Barbosa and Lagrou, Katrien and Hubka, Vit and Pontes, Laís and Schreiber, Angélica Zaninelli and Robbins, Nicole and Cowen, Leah E and Dos Reis, Thaila Fernanda and Goldman, Gustavo H},
title = {Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.01723-26}
}
EUVIMED